Fingerprint
Dive into the research topics of 'Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies
Karen W.L. Yee, Anne Hagey, Srdan Verstovsek, Jorge Cortes, Guillermo Garcia-Manero, Susan M. O'Brien, Stefan Faderl, Deborah Thomas, William Wierda, Steven Kornblau, Alessandra Ferrajoli, Maher Albitar, Evelyn McKeegan, David R. Grimm, Toby Mueller, Rhonda R. Holley-Shanks, Leonardo Sahelijo, Gary B. Gordon, Hagop M. Kantarjian, Francis J. Giles
Research output: Contribution to journal › Article › peer-review
79
Scopus
citations